Natural history of young-adult amyotrophic lateral sclerosis
- PMID: 18596241
- DOI: 10.1212/01.wnl.0000312378.94737.45
Natural history of young-adult amyotrophic lateral sclerosis
Abstract
Background: Amyotrophic lateral sclerosis (ALS) affects people of all ages, but whether the wide range of age at onset is due to distinct diseases or merely reflects phenotypic variability of the same disorder is still unknown. The purpose of this study is to describe clinical and prognostic features of young-adult ALS, with onset before age 40 years, and to compare them with features of the common adult-onset type.
Methods: We analyzed clinical features and long-term follow-up of 57 young-adult ALS patients, with disease onset between 20 and 40 years, and compared them with 450 patients affected by adult-onset ALS.
Results: We found that the majority of young-adult patients showed a predominant upper motor neuron (p-UMN) ALS, characterized by marked spastic paraparesis, with lower motor neuron signs confined to the upper limbs. The proportion of patients with p-UMN ALS phenotype was 59.6% in the young-adult patients and 17.4% in the adult-onset form (p < 0.0001). Young-adult ALS with p-UMN phenotype had longer survival than did the classic phenotype: median survival was 74 months (range 10-226, 95% CI 60.61-87.38) in the former and 56 months (range 6-106, 95% CI 48.65-63.34) in the latter (p = 0.03). In the young-adult patients, a marked male excess was observed in the p-UMN ALS group (5.8:1), whereas the ratio of men to women was 1.1:1 in the classic phenotype (p = 0.01).
Conclusions: Our findings show that young-adult amyotrophic lateral sclerosis with the predominant upper motor neuron phenotype represents a distinctive clinical variant characterized by a unique clinical pattern, longer survival, and male prevalence.
Comment in
-
From clues to mechanisms: understanding ALS initiation and spread.Neurology. 2008 Sep 16;71(12):872-3. doi: 10.1212/01.wnl.0000325992.50108.60. Neurology. 2008. PMID: 18794489 No abstract available.
-
Natural history of young-adult amyotrophic lateral sclerosis.Neurology. 2009 Aug 25;73(8):648-9; author reply 649-50. doi: 10.1212/WNL.0b013e3181b28674. Neurology. 2009. PMID: 19704088 No abstract available.
-
Natural history of young-adult amyotrophic lateral sclerosis.Neurology. 2009 Aug 25;73(8):649; author reply 649-50. Neurology. 2009. PMID: 19711535 No abstract available.
Similar articles
-
Uncovering amyotrophic lateral sclerosis phenotypes: clinical features and long-term follow-up of upper motor neuron-dominant ALS.Amyotroph Lateral Scler. 2011 Jul;12(4):278-82. doi: 10.3109/17482968.2011.580849. Amyotroph Lateral Scler. 2011. PMID: 21702734
-
Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up.Arch Neurol. 2007 Feb;64(2):232-6. doi: 10.1001/archneur.64.2.232. Arch Neurol. 2007. PMID: 17296839
-
The natural history of primary lateral sclerosis.Neurology. 2006 Mar 14;66(5):647-53. doi: 10.1212/01.wnl.0000200962.94777.71. Neurology. 2006. PMID: 16534101
-
Young-onset sporadic amyotrophic lateral sclerosis: a distinct nosological entity?Amyotroph Lateral Scler. 2007 Dec;8(6):323-7. doi: 10.1080/17482960701553956. Epub 2007 Aug 7. Amyotroph Lateral Scler. 2007. PMID: 17852021 Review.
-
Progressive spastic paraparesis: hereditary spastic paraplegia and its relation to primary and amyotrophic lateral sclerosis.Semin Neurol. 2001 Jun;21(2):199-207. doi: 10.1055/s-2001-15265. Semin Neurol. 2001. PMID: 11442328 Review.
Cited by
-
Therapeutics with SPION-labeled stem cells for the main diseases related to brain aging: a systematic review.Int J Nanomedicine. 2014 Aug 11;9:3749-70. doi: 10.2147/IJN.S65616. eCollection 2014. Int J Nanomedicine. 2014. PMID: 25143726 Free PMC article.
-
Psychiatric Symptoms in Amyotrophic Lateral Sclerosis: Beyond a Motor Neuron Disorder.Front Neurosci. 2019 Mar 11;13:175. doi: 10.3389/fnins.2019.00175. eCollection 2019. Front Neurosci. 2019. PMID: 30914912 Free PMC article. Review.
-
New ALS-Related Genes Expand the Spectrum Paradigm of Amyotrophic Lateral Sclerosis.Brain Pathol. 2016 Mar;26(2):266-75. doi: 10.1111/bpa.12354. Brain Pathol. 2016. PMID: 26780671 Free PMC article. Review.
-
Changes in the concentrations of trimethylamine N-oxide (TMAO) and its precursors in patients with amyotrophic lateral sclerosis.Sci Rep. 2020 Sep 16;10(1):15198. doi: 10.1038/s41598-020-72184-3. Sci Rep. 2020. PMID: 32938991 Free PMC article.
-
Temporal stratification of amyotrophic lateral sclerosis patients using disease progression patterns.Nat Commun. 2024 Jul 8;15(1):5717. doi: 10.1038/s41467-024-49954-y. Nat Commun. 2024. PMID: 38977678 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous